3 insiders bought €1.6M of shares over the last 90 days, the latest by Kurzius Lawrence Erik, filed 17 Sept 2026.
+4 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Cooper Companies, Inc. Hold (neutral), based on 15 analysts. Average price target: US$65.80.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended October 2025 · cache
25 of 999 declarations
In December 2025, purchases bunched up at Cooper Companies, Inc. (Healthcare & Pharma): from December 16 to December 22, 5 filers bought EUR 1,110,346 worth, including Albert G. White III (President & CEO) for EUR 687,390 on December 16. The same executive bought EUR 586,690 on September 5, 2025, and director Lawrence Erik Kurzius EUR 476,206 on September 16, 2026. The record's 23 purchases total EUR 4,830,167 (median EUR 140,432) and make up 10% of open-market trades; 20 cluster-buy filings are recorded.
The 218 sales weigh EUR 330,053,813, with a median of EUR 559,509. Robert S. Weiss sold EUR 22,471,825 on June 27, 2016 as President & CEO, then EUR 14,367,489 on March 7, 2024 as a director; Albert G. White III EUR 13,031,201 on March 8, 2021.
Of 999 filings from 31 filers, 415 are option exercises and 293 are grants. Agostino Ricupati (SVP & CAO) files 112 and Daniel G. McBride 87. The year 2016 has 154 filings, 2022 only 50. The last twelve months total 46, of which 10 purchases and no sale. The 18 purchases tracked at 90 days show a median of 13% with 67% of cases positive, recorded past results, not a forecast.
Insider filings
Over the last 90 days, 5 filings published between 15 September and 17 September 2026: 5 open-market purchases by insiders for €1.6M. Largest amounts: Kurzius Lawrence Erik (Director), purchases of €941k; Rosebrough Walter M Jr (Director), purchases of €467k; Keel Paul A (Director), purchases of €215k.
Recent news
In an article dated 1 October 2026, Yahoo Finance reported: "New CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging Solution", 15 days after the share purchase by Kurzius Lawrence Erik (€476k).
"Seneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision care" (Yahoo Finance, 29 September 2026), 13 days after the share purchase by Kurzius Lawrence Erik (€476k).
From Zonebourse on 18 September 2026: "Jana presse Cooper de remplacer son PDG et d'envisager des cessions d'actifs après des revers de performance" (headline in French), in the same week as the share purchase by Kurzius Lawrence Erik (€476k).
Headlines quoted as published, with source and date. The gap to insider purchases is computed from the filings and implies no link between the article and the purchase. Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 15 October 2026 (UTC)
Headquarters: San Ramon, United States · Founded: 1958 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Oct 2025 | 4.09 bn USD | 374.9 m USD | 1.87 USD | n.d. | 10-K |
| Oct 2024 | 3.90 bn USD | 392.3 m USD | 1.96 USD | n.d. | 10-K |
| Oct 2023 | 3.59 bn USD | 294.2 m USD | 1.48 USD | 0.01 USD | 10-K |
| Oct 2022 | 3.31 bn USD | 385.8 m USD | 1.94 USD | 0.01 USD | 10-K |
| Oct 2021 | n.d. | 2.94 bn USD | 59.16 USD | 0.03 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.